[1] 王云萍,容俊,朱银翠.贫困地区妇女宫颈癌流行病学调查及HPV筛查结果分析[J].中国妇幼保健,2019,34(21):5015-5017. [2] 秦远,黄娜,谭燕, 等.宫颈癌中肿瘤免疫细胞浸润模式及预后价值[J].西部医学,2019,31(11):1651-1656. [3] 梅燕,董良波,陈丹.宫颈癌患者感染乳头瘤病毒亚型和其他病原体感染检测及血清炎症因子水平分析[J].中国病原生物学杂志,2018,13(12):1405-1408. [4] 李栋,邹梦娟,王亮, 等.蛋白营养不良与能量营养不良状态下脓毒症大鼠凝血的变化[J].中华危重病急救医学,2019,31(9):1113-1117. [5] YOSHINO Y, TAGUCHI A, SHIMIZUGUCHI T, et al. A low albumin to globulin ratio with a high serum globulin level is a prognostic marker for poor survival in cervical cancer patients treated with radiation based therapy[J].Int J Gynecol Cancer,2019,29(1):17-22. [6] 罗皓,黄君.白蛋白-胆红素分级评估肝细胞癌预后的价值[J].临床肝胆病杂志,2019,35(7):1608-1612. [7] 黄艮平.宫颈腺癌的病因学研究进展[J].国际妇产科学杂志,2019,46(1):104-108. [8] 王夺,梁夏宜,刘军杰, 等.术前血清前白蛋白水平与甲胎蛋白阴性肝细胞癌患者预后的关系[J].中国癌症防治杂志,2019,11(4):323-326. [9] 黄培坚,潘志锋,苏鸿凯.联合CRP/ALB比值和NLR对宫颈鳞状细胞癌预后的评估价值[J].转化医学杂志,2019,8(2):85-88. [10] HE X, LI J P, LIU X H, et al. Prognostic value of C-reactive protein/albumin ratio in predicting overall survival of Chinese cervical cancer patients overall survival: comparison among various inflammation based factors[J].J Cancer,2018,9(10):1877-1884. [11] LV G Y, AN L, SUN X D, et al. Pretreatment albumin to globulin ratio can serve as a prognostic marker in human cancers: a meta-analysis[J].Clin Chim Acta,2018,476:81-91. [12] OBERMAIR A, SIMUNOVIC M, ISENRING L, et al. Nutrition interventions in patients with gynecological cancers requiring surgery[J].Gynecol Oncol,2017,145(1):192-199. [13] RODRIGUES C S, LACERDA M S, CHAVES G V. Patient Generated Subjective Global Assessment as a prognosis tool in women with gynecologic cancer[J].Nutrition,2015,31(11-12):1372-1378. [14] ZHENG R R, HUANG M, JIN C, et al. Cervical cancer systemic inflammation score: a novel predictor of prognosis[J].Oncotarget,2016,7(12):15230-15242.
2021, Vol. 38 
